Clinical trial
A Phase II Study Using Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma
NCT01643824 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study Using Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma
- Lead sponsor
- National Cancer Center, Korea
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 7, 2012
- Completion date
- April 30, 2017
- Enrollment
- 112 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma